• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

How Do Thyroid Levels Impact Life Expectancy?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Thyroid dysfunction: Thyrotropin and free thyroxine (FT4) levels outside the reference ranges
  • Subclinical thyroid dysfunction: Thyrotropin levels outside the reference range but FT4 levels within the reference range
  • Cut-offs are arbitrary and set at 2.5th and 97.5th %tiles of normal populations but does not account for clinical outcomes
  • Both thyroid and subclinical thyroid dysfunction associated with increased mortality, coronary heart disease and heart failure
  • Clinical outcomes for patients who are considered ‘euthyroid’ remain unclear
  • Bano et al. (JAMA, 2017) investigated the association between thyroid function and life expectancy and CVD among euthyroid individuals

METHODS:

  • Population based, prospective cohort study
  • Participants had known thyroid disease and thyrotropin and free thyroxine (FT4) levels within the reference range
  • Multistate life tables were used to calculate total life expectancy and life expectancy +/- CVD, stratified by thyrotropin and FT4 tertiles
  • Life expectancy estimates in men and women aged 50 years and older were obtained using prevalence, incidence rates, and hazard ratios for 3 transitions (healthy to CVD, healthy to death, and CVD to death), adjusting for sociodemographic and cardiovascular risk factors

RESULTS:

  • The mean (SD) age of the 7,785 participants was 64.7 (9.8) years, and 52.5% were women
  • Median follow-up of 8.1 years
  • Compared with those in the lowest tertile, those in the highest thyrotropin tertile lived longer
    • Women
      • 1.4 (95% CI 0.2 to 2.4) years
      • 0.9 (95% CI −0.2 to 2.0) years without CVD
    • Men
      • 2.0 (95% CI 1.0 to 2.8) years
      • 1.5 (95% CI 0.2 to 2.6) years without CVD
    • Compared with those in the lowest tertile, those in the highest FT4 tertile did not live as long
      • Women
        • −3.5 (95% CI, −5.6 to −1.5) years
        • −2.5 (95% CI, −4.4 to −0.7) years without CVD
      • Men
        • −3.2 (95% CI, −5.0 to −1.4) years
        • −3.1 (95% CI, −4.9 to −1.4) years without CVD

CONCLUSION:

  • Individuals with low-normal thyroid function live up to 3.5 years longer overall and up to 3.1 years longer without CVD than participants with high-normal thyroid function
  • Authors suggest low-normal thyroid function may promote energy conservation or an association with a heritable phenotype associated with longevity
  • Known deleterious effects of high thyroid function may extend into the high-normal range
  • The authors recommend that guidance committees reevaluate current thyroid function reference ranges

Learn More – Primary Sources:

Association of Thyroid Function With Life Expectancy With and Without Cardiovascular Disease

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Should Levothyroxine be Used to Treat Subclinical Hypothyroidism?
Prolactinoma: Early Detection, Evaluation and Management

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site